Published in Semin Respir Crit Care Med on January 06, 2011
Approach of the treatment for pneumothorax. J Thorac Dis (2014) 0.94
Bilateral bullectomy through uniportal video-assisted thoracoscopic surgery combined with contralateral access to the anterior mediastinum. J Bras Pneumol (2013) 0.78
Primary and Secondary Spontaneous Pneumothorax: Prevalence, Clinical Features, and In-Hospital Mortality. Can Respir J (2017) 0.75
Birt-Hogg-Dubé syndrome: a literature review and case study of a Chinese woman presenting a novel FLCN mutation. BMC Pulm Med (2017) 0.75
Immune targeting of the pleural space by intercostal approach. BMC Pulm Med (2015) 0.75
Pneumothorax in a single lung patient. West J Emerg Med (2012) 0.75
Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest (2006) 4.77
Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest (2006) 3.59
Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther (2005) 2.66
Monoamine transporters and psychostimulant drugs. Eur J Pharmacol (2003) 2.60
Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil. J Pharmacol Exp Ther (2009) 1.88
Chest ultrasonography: where's the beef? Chest (2011) 1.39
First, do no harm: less training ≠ quality care. Am J Crit Care (2012) 1.38
Interaction of amphetamines and related compounds at the vesicular monoamine transporter. J Pharmacol Exp Ther (2006) 1.35
Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration. J Pharmacol Exp Ther (2005) 1.29
Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain. Eur J Pharmacol (2002) 1.23
Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction. Biochem Pharmacol (2007) 1.20
Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann N Y Acad Sci (2006) 1.20
The role of corticosterone in food deprivation-induced reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl) (2002) 1.17
Appetite suppressants, cardiac valve disease and combination pharmacotherapy. Am J Ther (2009) 1.17
Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving. Biol Psychiatry (2013) 1.16
Therapeutic potential of monoamine transporter substrates. Curr Top Med Chem (2006) 1.14
Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest (2003) 1.13
Serotonin releasing agents. Neurochemical, therapeutic and adverse effects. Pharmacol Biochem Behav (2002) 1.09
Methods and definition of terms: effectiveness of continuing medical education: American College of Chest Physicians Evidence-Based Educational Guidelines. Chest (2009) 1.08
Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions. AAPS J (2007) 1.06
Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction. Exp Clin Psychopharmacol (2008) 1.06
Medial prefrontal cortex neuronal activation and synaptic alterations after stress-induced reinstatement of palatable food seeking: a study using c-fos-GFP transgenic female rats. J Neurosci (2012) 1.05
An n-3 fatty acid deficiency impairs rat spatial learning in the Barnes maze. Behav Neurosci (2009) 1.03
Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs. Eur J Pharmacol (2012) 1.02
Closed pleural biopsy: not dead yet! Chest (2006) 1.02
Therapeutic and adverse actions of serotonin transporter substrates. Pharmacol Ther (2002) 1.02
Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis. Synapse (2005) 1.02
3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse (2004) 1.02
Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction. Trends Pharmacol Sci (2006) 1.01
Appetite suppressants as agonist substitution therapies for stimulant dependence. Ann N Y Acad Sci (2002) 1.00
Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats. Br J Pharmacol (2014) 0.99
Effect of fenfluramine on reinstatement of food seeking in female and male rats: implications for the predictive validity of the reinstatement model. Psychopharmacology (Berl) (2011) 0.98
Dopamine/serotonin releasers as medications for stimulant addictions. Prog Brain Res (2008) 0.96
Executive summary: effectiveness of continuing medical education: American College of Chest Physicians Evidence-Based Educational Guidelines. Chest (2009) 0.96
Serotonergic drugs and valvular heart disease. Expert Opin Drug Saf (2009) 0.96
Pathogenesis and treatment of primary spontaneous pneumothorax: an overview. Respiration (2003) 0.95
Effects of chronic social stress on neuroendocrine responsiveness to challenge with ethanol, dexamethasone and corticotropin-releasing hormone. Neuroendocrinology (2005) 0.94
(+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane. J Pharmacol Exp Ther (2005) 0.94
Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease. J Pharmacol Exp Ther (2006) 0.93
Pleural controversy: aetiology of pneumothorax. Respirology (2011) 0.93
Pneumothorax and air travel: lessons learned from a bag of chips. Chest (2009) 0.91
Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transporters. J Pharmacol Exp Ther (2012) 0.91
(+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters. J Pharmacol Exp Ther (2003) 0.89
Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain. Eur J Pharmacol (2011) 0.88
Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levels. J Pharmacol Exp Ther (2007) 0.88
Evidence for noncompetitive modulation of substrate-induced serotonin release. Synapse (2010) 0.87
Serotonin (5-HT) transporter ligands affect plasma 5-HT in rats. Ann N Y Acad Sci (2008) 0.86
Introduction: Effectiveness of continuing medical education: American College of Chest Physicians Evidence-Based Educational Guidelines. Chest (2009) 0.86
Misuse of Novel Synthetic Opioids: A Deadly New Trend. J Addict Med (2017) 0.85
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat. Drug Metab Dispos (2013) 0.85
Quality improvement and pay for performance: barriers to and strategies for success. Chest (2013) 0.84
Methamphetamine and idiopathic pulmonary arterial hypertension: role of the serotonin transporter. Chest (2007) 0.84
Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats. Br J Pharmacol (2014) 0.84
Effects of stress modulation on morphine-induced conditioned place preferences and plasma corticosterone levels in Fischer, Lewis, and Sprague-Dawley rat strains. Psychopharmacology (Berl) (2006) 0.83
Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension. PLoS One (2011) 0.82
Will performance measurement lead to better patient outcomes? What are the roles of the National Quality Forum and Medical Specialty Societies? Chest (2012) 0.82
High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse (2003) 0.82
A pulmonary myth unmasked? Chest (2002) 0.82
Serotonergic responsiveness in human cocaine users. Drug Alcohol Depend (2006) 0.81
Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transporters. J Med Chem (2004) 0.80
Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or 'Serotoni'). Drug Test Anal (2014) 0.80
Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes. Psychopharmacology (Berl) (2014) 0.79
Ventilator-associated events: the new definition. Am J Crit Care (2014) 0.79
An official multi-society statement: ventilator-associated events: the new definition. Crit Care Med (2014) 0.79
CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men. Am J Drug Alcohol Abuse (2011) 0.78
Psychoactive 'bath salts': compounds, mechanisms, and toxicities. Neuropsychopharmacology (2013) 0.78
Differential modulation of cocaine's discriminative cue by repeated and variable stress exposure: relation to monoamine transporter levels. Neuropharmacology (2012) 0.78
Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Psychopharmacology (Berl) (2015) 0.78
The Changing Face of Recreational Drug Use. Cerebrum (2016) 0.77
An official multi-society statement: ventilator-associated events--the new definition. Ann Am Thorac Soc (2014) 0.77
Rats preexposed to MDMA display attenuated responses to its aversive effects in the absence of persistent monoamine depletions. Psychopharmacology (Berl) (2011) 0.76
Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expression. Ann N Y Acad Sci (2004) 0.76
Endogenous corticotropin releasing factor regulates adrenergic and opioid receptors. Peptides (2002) 0.76
Death to the garden hose? Chest (2010) 0.75
The authors reply. Crit Care Med (2014) 0.75
American College of Chest Physicians evidence-based guidelines--the next generation: considering resource use and evolution to a single grading system. Chest (2006) 0.75
To bleb or not to bleb? Chest (2007) 0.75
Age differences in (±) 3,4-methylenedioxymethamphetamine (MDMA)-induced conditioned taste aversions and monoaminergic levels. Dev Psychobiol (2013) 0.75
An official multi-society statement: ventilator-associated events: the new definition. Chest (2014) 0.75
Targeted screening for biogenic amine transporters: potential applications for natural products. Life Sci (2005) 0.75
First, do no harm: less training ≠ quality care. Chest (2012) 0.75
Massive mediastinal and hilar adenopathy in a young African-American man. J Miss State Med Assoc (2002) 0.75